Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study

In the setting of prior myocardial infarction, the oral antiplatelet ticagrelor added to aspirin reduced the risk of recurrent ischemic events, especially, in those with diabetes mellitus. Patients with stable coronary disease and diabetes are also at elevated risk and might benefit from dual antipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Deepak L., Fox, Kim, Harrington, Robert A., Leiter, Lawrence A., Mehta, Shamir R., Simon, Tabassome, Andersson, Marielle, Himmelmann, Anders, Ridderstråle, Wilhelm, Held, Claes, Steg, Philippe Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522985/
https://www.ncbi.nlm.nih.gov/pubmed/30788847
http://dx.doi.org/10.1002/clc.23164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522985/
https://www.ncbi.nlm.nih.gov/pubmed/30788847
http://dx.doi.org/10.1002/clc.23164

Ejemplares similares